Clinical Trial Update: Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)

View source ↗

Summary

The ASPIRE study investigates active surveillance in prostate cancer. It uses imaging to detect radiographic progression as an endpoint.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Yale University | Conditions: Prostate Cancer | Status: COMPLETED